Literature

Extraction of urinary catecholamines and metanephrines using EVOLUTE® EXPRESS WCX

Written by Biotage | Dec 6, 2025 5:45:00 AM

For research use only. NOT for use in diagnostic procedures.

 

Figure 1. Structures of dopamine, epinephrine and norepinephrine left), metanephrine, normetanephrine and 3-methoxytyramine (right).

Introduction

This application note describes a mixed-mode weak cation exchange SPE protocol for the extraction of three catecholamines (epinephrine, norepinephrine and dopamine) and three metanephrine metabolites (metanephrine, normetanephrine and 3-methoxytyramine) from urine prior to LC-MS/MS detection.

The method described in this application achieves high reproducible recoveries for a number of common catecholamine analytes in urine.

EVOLUTE® EXPRESS SPE products dramatically improve flow characteristics, and enhance sample preparation productivity. By truly eliminating the need for column conditioning and equilibration, samples can be prepared using a simple, fast load-wash-elute procedure.

Analytes

Epinephrine, Norepinephrine, Dopamine, Metanephrine, Normetanephrine and 3-Methoxytyramine (Sigma Aldrich Chemical Co, Poole, UK).

Internal standards

D6-Epinephrine, D6-Norepinephrine, D4-Dopamine, D3-Metanephrine, D3-Normetanephrine (Sigma Aldrich Chemical Co, Poole, UK).

Solid Phase Extraction procedure

Format:

EVOLUTE® EXPRESS WCX 10 mg fixed well plate, part number 602-0010-PX01.

Sample pretreatment:

Mix urine (75 µL) with 10 µL of internal standard solution and 250 mM ammonium acetate solution (150 µL). Mix.

Condition:

OPTIONAL. NOT REQUIRED in load-wash-elute procedure. Condition wells with methanol (500 µL). Processing conditions: load at 1–2 psi when using a Biotage® PRESSURE+ 96 manifold.

Equilibration:

OPTIONAL. NOT REQUIRED in load-wash-elute procedure. Condition wells with 10 mM ammonium acetate (500 µL) Processing conditions: load at 1–2 psi when using a Biotage® PRESSURE+ 96 manifold.

Sample loading:

Load pre-treated urine (150 µL). Processing conditions:
load at 1–2 psi when using a Biotage® PRESSURE+ 96 manifold.

Wash 1:

Elute interferences with 10mM ammonium acetate (500 µL). Processing conditions: load at 1–2 psi, followed by 50 psi for 2s when using a Biotage® PRESSURE+ 96 manifold.

Wash 2:

Elute interferences with propan-2-ol (500 µL). Processing conditions: load at 1–2 psi when using a Biotage® PRESSURE+ 96 manifold. Dry thoroughly at 50 psi for 1 min.

Elution:

Elute analytes with 125 µL of water: propan-2-ol (85:15, v/v) containing formic acid (0.1% v/v). Processing conditions: load at 1–2 psi when using a Biotage® PRESSURE+ 96 manifold. Dry thoroughly at 50 psi for 1 min.

Post elution:

Cap the SPE plate. No evaporation step is required.

UPLC conditions

Instrument

Shimadzu Nexera UHPLC system

Column

ACE Excel 1.7 C18 PFP 100 x 2.1 mm

Guard

Securityguard C18

Mobile phase

A: Water containing 0.25 mM ammonium formate and formic acid
B: Methanol containing 0.25 mM ammonium formate and formic acid
(See “Reagent Preparation” for preparation procedure)

Flow rate:

0.4 mL min-1

Injection

7.5 µL

Gradient

Initial to 1.3 min hold at 5 % B
1.4 to 4.3 min hold at 95 % B
4.4 to 7.5 min hold at 5 % B

Column temperature

40 °C

Sample temperature

5 °C

Table 1. Typical retention times for catecholamines and metanephrines.

Compound

Retention time (min)

Epinephrine

0.76

Norepinephrine

1.02

Dopamine

1.24

Normetanephrine

1.22

Metanephrine

1.24

3-Methoxytyramine

2.9

Refer also to additional notes for more information.

Switching valve settings

Initial setting: Waste
Switch to MS: 0.4 min
Switch to waste: 3.4 min
NOTE: Other U/HPLC methods may be appropriate.

MS conditions

Ions were selected in order to achieve maximum sensitivity using multiple reaction monitoring.

Instrument

AB Sciex 5500

Curtain gas

35

Collision gas

7

Ion spray voltage

5500

Temperature

700 °C

Ion Source Gas 1 (GS1)

50

Ion Source Gas (GS2)

50

MRM parameters

Table 2. MRM parameters.

Analyte

Transition

DP, V 

EP, V

CE, V 

CXP, V

Epinephrine

166.1 > 107.1

148

8

24

16

D6-Epinephrine

172.1 > 112.1

148

8

24

16

Norepinephrine

152.1 > 107.1

25

2

22

25

D6-Norepinephrine

158.1 > 111.1

25

2

22

25

Dopamine

154.1 > 91.1

50

9

29

13

D4-Dopamine

158.1 > 95.1

50

9

29

13

Metanephrine

180.1 > 148.0

25

8

22

16

D3-Metanephrine

183.1 > 151.0

25

8

22

16

Normetanephrine

166.1 > 134.0

25

9

20

16

D3-Normetanephrine

169.1 > 137.0

25

9

20

16

3-Methoxytyramine

151.2 > 90.9

110

9

26

11

Results

Extraction recoveries were calculated at the top calibration concentration as follows:

Table 3. Top calibration concentrations used for recovery calculation.

Analytes

Top Standard Concentration

Norepinephrine

250 ng/mL

Epinephrine

25 ng/mL

Dopamine

625 ng/mL

Normetanephrine

125 ng/mL

Metanephrine

125 ng/mL

3 Methoxytyramine

250 ng/mL

Data is summarized from the results of n=8 extracted samples compared to n=5 blank samples fortified with an amount of analytes equivalent to 100% after extraction.

Table 4. Extraction recoveries (Manual procedure)

 

Traditional Method

Load-Wash-Elute Method

 

Extraction Recovery

% RSD

Extraction Recovery

% RSD

Norepinephrine

88.8

3.5

76.1

7.0

Epinephrine

109.3

7.0

108.3

8.5

Dopamine

91.8

3.1

88.2

3.3

Normetanephrine

87.9

6.6

83.6

8.6

Metanephrine

83.3

5.0

88.4

6.8

3- Methoxytyramine

84.2

4.2

83.6

2.1

Table 5. Extraction recoveries (Biotage® ExtraheraTM procedure)

 

Traditional Method

Load-Wash-Elute Method

 

Extraction Recovery

% RSD

Extraction Recovery

% RSD

Norepinephrine

77.4

4.9

69.5

5.8

Epinephrine

110.4

7.4

93.7

6.0

Dopamine

87.4

4.2

88.4

2.0

Normetanephrine

80.7

7.4

77.2

7.2

Metanephrine

83.5

5.8

82.4

5.7

3-Methoxytyramine

78.0

5.8

80.1

4.8

Linearity was determined between 0.1 and 25 ng/mL for epinephrine, between 0.5 and 125 ng/mL for metanephrine and normetanephrine, between 1 and 250 ng/mL for norepinephrine and 3-methoxytyramine and between 2.5 and 625 ng/mL for dopamine. Calibration lines for each analyte are displayed on page 4. Similar performance was observed for both standard and Load-Wash-Elute methods, whether processed manually (using the Biotage® Pressure +96 positive pressure manifold), or Biotage® ExhraheraTM.

Figure 2. Representative calibration plots of catecholamines.

Preparation of standards

The calculations below assume all analyte stocks solutions are at a concentration of 1 mg/mL.

  1. An epinephrine substock solution A was prepared by diluting 5 µL of epinephrine stock to 1 mL with water.
  2. A combined substock solution B was prepared by diluting norepinephrine stock (10 µL), 3-methoxytyramine stock (10 µL), metanephrine stock (5 µL), normetanephrine stock (5 µL), and 200 µL of substock A (200 µL), to 1 mL with water.
  3. A final catecholamine and metanephrines substock solution C was produced by diluting 10 µL of dopamine stock and 400 µL of substock B to a total volume of 1 mL with water. The catecholamine and metanephrines substock solution C contained dopamine at 10 µg/mL, norepinephrine and 3-methoxytyramine at 4 µg/mL, metanephrine and normetanephrine at 2 µg/mL and epinephrine at 0.4 µg/mL.
  4. A top concentration urine solution was then prepared by diluting the final catecholamine and metanephrines substock C by a factor of 1 in 16 with urine giving concentrations of dopamine of 625 ng/mL down to epinephrine at 25 ng/mL. This solution was then further
    diluted in urine to generate the standards as listed below.

A combined deuterated internal standard (IS) solution was also prepared in water using separate 100 µg/mL stock solutions:

  1. An epinephrine IS substock D solution was prepared by diluting a 5 µL volume of epinephrine IS stock to 1 mL using water.
  2. A combined IS substock E was prepared by diluting normetanephrine IS stock (5 µL), metanephrine IS stock(5 µL) and of epinephrine IS substock D (200 µL) to 1 mL with water.
  3. A catecholamine and metanephrines IS substock F was prepared by diluting norepinephrine IS stock (5 µL) and 500 µL of the combined IS substock E to 1 mL with water.
  4. A final catecholamine and metanephrines IS substock G was combined by diluting 5 µL dopamine IS stock and 400 µL catecholamine and metanephrines IS stock F to 1 mL with 250 mM ammonium acetate. The final catecholamine and metanephrines IS substock solution G contained dopamine internal standard at 500 ng/mL, norepinephrine IS at 200 ng/mL, metanephrine and normetanephrine IS at 100 ng/mL and epinephrine IS at 20 ng/mL.

All substock and internal standard solutions were prepared daily to prevent degradation.

Table 6. Concentrations of standard solutions used.

Analyte

Std 7

Std 6

Std 5

Std 4

Std 3

Std 2

Std 1

Norepinephrine

250

125

50

20

7.5

2.5

1

Epinephrine

25

12.5

5

2

0.75

0.25

0.1

Dopamine

625

312.5

125

50

18.75

6.25

2.5

Normetanephrine

125

62.5

25

10

3.75

1.25

0.5

Metanephrine

125

62.5

25

10

3.75

1.25

0.5

3-Methoxytyramine

250

125

50

20

7.5

2.5

1

Other chemicals & reagents

  • Water (18.2 MΩ.cm) drawn from a Direct-Q 5 water purifier (Merck Millipore, Watford, UK).
  • Ammonium Acetate & Ammonium Formate- Sigma-Aldrich Chemical Co. (Poole, UK).
  • Propan-2-ol Sigma-Aldrich Chemical Co. (Poole, UK).
  • Methanol, MS grade Sigma-Aldrich Chemical Co. (Poole, UK).
  • Urine (MSG5000, ultra low hormone, steroid, drug and alcohol free) was sourced from Golden West Biologicals Inc, Temecula, CA, USA

Reagent preparation

  • SPE elution solvent, prepared daily
    • 15 mL of IPA was transferred into a bottle, to this was added 85 mL of water and then 100µL of formic acid.
  • 0.05% formic acid
    • 250 mL water was transferred to a bottle and to this was added 125 µL of formic acid
  • 10 mM Ammonium acetate
    • Approximately 350 mg of ammonium acetate was accurately weighed and emptied into a bottle, to this was added water such that 500 mL water was added for every 385.4 mg of ammonium acetate weighed.
  • HPLC mobile phase A and B
    • Ammonium formate/formic acid. A concentrated solution was prepared by combining 38.75 mg of ammonium formate, with 71 µL of formic acid and diluting with water to a total volume of 5 mL. This was then added to both mobile phases (A: water and B: methanol) as 500 µL of the ammonium formate / formic acid solution per litre of mobile phase.

All other reagents used were pure solvents. The catecholamine and metanephrine sub stocks used were prepared in water.

Additional notes

  1. The method described in this application note covers different calibration ranges because of wide native endogenous levels expected from one analyte to another in urine.
  2. The method can either be performed using either a traditional SPE procedure or the EVOLUTE® EXPRESS Load-Wash-Elute method (with no conditioning or equilibration steps).
  3. Stripped urine (from Golden West) was used to construct calibration lines as control urine contained significant values of all analytes. Comparison plots of blank and lowest concentration standards indicate however that if ultra low measurement of epinephrine or noprepinephrine is required then some form of proxy matrix or synthetic urine should be used instead for calibration line and low concentration QC preparation.
  4. Catecholamines are relatively unstable so a number of handling procedures were employed for these analytes. Analytes were purchased as solids, stored according to their label and regularly re-prepared. Internal standards were regularly compared for sensitivity alongside analytes increasing their concentrations if necessary. A low autosampler temperature of approximately 5 oC is also recommended to minimize any potential autosampler instability. Working solutions were prepared from stocks on a daily basis.
  5. The method described here is suitable for urine only. For extraction from plasma matrix, see Biotage application note AN874.
  6. It is essential to the method performance that all traces of wash 2 solvent is removed prior to analyte elution. If using The Biotage® ExtraheraTM (with a dual flow head) or Biotage ® Pressure +96 manifold, use of a maximum flow setting for at least 10 minutes is recommended. If using other equipment optimize drying conditions to ensure wash 2 solvent is fully removed.
  7. With the chromatographic system documented in this application note, three of the components: dopamine, normetanephrine and metanephrine along with their deuterated internal standards elute very close to each other. Minor changes to gradient conditions did not further resolve these peaks significantly. However, analysis of individual components (both analytes and internal standards) confirmed that there was no contribution of one of these analytes or internal standards to the MS transition of another.
  8. The chromatography system relies on the combination of a C18 guard followed by a PFP analytical column. The retention times were found to vary slightly depending upon the ages of the columns and so the timings quoted in the application note should only be used as an approximate guide.
  9. As the method does not involve an evaporation step extraction recoveries were calculated by comparing extracts of spiked samples + 10 µL of water compared to extracts of blank samples + 10 µL of fortified analytes in water.
  10. Due to the high levels of dopamine in urine the calibration line for this analyte could show some non-linearity at higher concentrations due to saturation. If this is significant and high concentrations are expected then the dopamine can be ‘detuned’ by for example reducing its collision energy from 29 V to 18 V. (see fig 3a and 3b below) The calibration details quoted in this application note were for correctly tuned dopamine with a linear fit.

Figure 3a. Dopamine plot showing some non-linearity.
Figure 3b. Detuned Dopamine giving linear plot.

Ordering information

Part Number

Description

Quantity

602-0010-PX01

EVOLUTE® EXPRESS WCX 10 mg Fixed Well Plate

1

414001

Biotage® ExtraheraTM Automation System

1

415040

Configuration Kit

96 Positions Dual Flow

1

414141

Extrahera clear tips

960

PPM-96

Biotage® PRESSURE+ 96 Positive Pressure Manifold (96 well)

1

121-5203

Collection plate, 2 mL, square

50

121-5204

Piercable sealing cap

50

Appendix: Biotage® Extrahera™ settings

The Load-Wash-Elute SPE method described in this application note was automated on the Biotage® Extrahera™ using EVOLUTE® EXPRESS WCX 10 mg plates. This appendix contains the
software settings required to configure Extrahera to run this method. An importable electronic copy of this method for Extrahera can be downloaded from www.biotage.com.

Using this automated procedure, 96 samples can be processed in a total of 51.52 mins.

Biotage® ExtraheraTM Data

Analyte

Recovery (n=8)*

% RSD

Linearity (r2)

LLOQ ng/mL

Norepinephrine

69.5

5.8

0.996

1

Epinephrine

93.7

6.0

0.991

0.1

Dopamine

88.4

2.0

0.993

2.5

Normetanephrine

77.2

7.2

0.998

0.5

Metanephrine

82.4

5.7

0.996

0.5

3-methoxytyramine

80.1

4.8

1.000

1

*Recovery measured at top calibration concentration

Method Name:

Metanephrines and Catecholamines in urine

Sample Plate/Rack:

2 mL sample plate, 96

Extraction Media:

EVOLUTE® EXPRESS WCX

Solvent properties

 

Solvent Description

1

Solvent description

2

Ammonium acetate 250mM

3

10 mM NH40Ac pH7

4

IPA

5

15% IPA 0.1% Formic acid

6

 

7

 

8

 

9

 

10

 

Solvent

1

2

3

4

5

6

7

8

9

10

Reservoir Type

Refillable

Non Refillable

Capacity

N/A

N/A

N/A

N/A

N/A

         

Aspiration flow rate (mL/min)

10

10

10

10

           

Dispense flow rate (mL/min)

20

20

5

5

           

Lower air gap flow rate (mL/min)

20

20

5

5

           

Lower air gap volume (µL)

5

5

5

5

           

Upper air gap flow rate (mL/min)

20

120

120

120

           

Upper air gap volume (µL)

100

100

100

100

           

Upper air gap dispense pause

300

300

300

300

           

Conditioning?

Yes

Yes

Yes

Yes

           

Conditioning number of times

2

2

3

3

           

Conditioning flow rate (mL/min)

20

20

5

5

           

Chlorinated

No

No

No

No

           

Serial dispense

No

No

No

No

           

 

 

Literature Number: AN871